TCTMD(@TCTMD) 's Twitter Profileg
TCTMD

@TCTMD

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at https://t.co/9j3KOiiahQ

ID:40042798

linkhttp://www.tctmd.com calendar_today14-05-2009 17:36:57

17,1K Tweets

26,1K Followers

6,6K Following

TCTMD(@TCTMD) 's Twitter Profile Photo

New expert consensus from subspecialties within European Society of Cardiology reveals that a team-approach towards revascularization decisions can be beneficial for patients with CTOs. Alfredo R Galassi and Emmanouil Brilakis share more details at TCTMD: tctmd.com/news/cto-diagn…

New expert consensus from subspecialties within @escardio reveals that a team-approach towards revascularization decisions can be beneficial for patients with CTOs. @alfredorgalassi and @esbrilakis share more details at TCTMD: tctmd.com/news/cto-diagn…
account_circle
TCTMD(@TCTMD) 's Twitter Profile Photo

Experts at call for a “patient-first” approach in treating CLTI after reviewing contradictory results from BEST-CLI and BASIL-2 trials. Input from Barry T. Katzen, MD, Darren Schneider, MD, Mehdi Shishehbor, DO, and more at TCTMD: tctmd.com/news/how-recon…

Experts at #ISET24 call for a “patient-first” approach in treating CLTI after reviewing contradictory results from BEST-CLI and BASIL-2 trials. Input from @DrBTKatzen, @VascularMD, @shishem, and more at TCTMD: tctmd.com/news/how-recon…
account_circle
TCTMD(@TCTMD) 's Twitter Profile Photo

The ORBITA-AF study reveals that a sham-based design is possible for AF ablation, but is it worth the effort? Head to TCTMD for opinions from Ayman Hussein MD, Dr Malcolm Finlay and more: tctmd.com/news/sham-cont…

The ORBITA-AF study reveals that a sham-based design is possible for AF ablation, but is it worth the effort? Head to TCTMD for opinions from @aymanhusseinmd, @mcfinlay and more: tctmd.com/news/sham-cont…
account_circle
TCTMD(@TCTMD) 's Twitter Profile Photo

An analysis of MR patients in France finds that M-TEER has a lower mortality risk than mitral valve surgery, but primarily for older patients with a higher baseline risk for surgery. Head to TCTMD for input from pierredeharo and Tsuyoshi Kaneko: tctmd.com/news/lower-mor…

An analysis of MR patients in France finds that M-TEER has a lower mortality risk than mitral valve surgery, but primarily for older patients with a higher baseline risk for surgery. Head to TCTMD for input from @deharo_pierre and @TsuyoshiKaneko1: tctmd.com/news/lower-mor…
account_circle
TCTMD(@TCTMD) 's Twitter Profile Photo

Julia Colombijn shares results indicating the systematic underrepresentation of CKD patients in cardiovascular clinical trials for this . Watch the full video here: tctmd.com/videos/tctmds-…

account_circle
TCTMD(@TCTMD) 's Twitter Profile Photo

Wayne Gao and Carl Lavie encourage ‘denormalizing’ sitting all day at work due to findings showing that short periods of physical activity can offset negative effects of prolonged sitting. More on findings and suggestions to shift workplace culture here: tctmd.com/news/short-bou…

Wayne Gao and Carl Lavie encourage ‘denormalizing’ sitting all day at work due to findings showing that short periods of physical activity can offset negative effects of prolonged sitting. More on findings and suggestions to shift workplace culture here: tctmd.com/news/short-bou…
account_circle
TCTMD(@TCTMD) 's Twitter Profile Photo

For patients receiving IV thrombolysis for acute ischemic stroke, adding argatroban or eptifibatide does not improve outcomes as shown in the MOST trial. Larry Goldstein, MD explains that other types of antithrombotics may be worth exploring. tctmd.com/news/most-epti…

For patients receiving IV thrombolysis for acute ischemic stroke, adding argatroban or eptifibatide does not improve outcomes as shown in the MOST trial. @LBGoldsteinMD explains that other types of antithrombotics may be worth exploring. #ISC24 tctmd.com/news/most-epti…
account_circle